文献速递围术期管理与 ERAS

多发性硬化患者心血管手术结局的全国性横断面研究

Outcomes of Cardiovascular Surgery in Patients With Multiple Sclerosis.
PubMed 文献 · JAMA Surg · 2026-01-01

采用平衡评分匹配队列分析发现,多发性硬化与住院死亡率或并发症风险增加无关,但常规出院回家比例较低。

要点

  • 多发性硬化患者心血管术后住院死亡率和复合并发症与无多发性硬化者无显著差异。
  • 多发性硬化患者常规出院回家比例显著低于无多发性硬化者(28% vs 36%)。
  • 住院费用和住院时长在两组间无显著差异。

核心结论

  • 多发性硬化与心血管手术患者住院死亡率或并发症增加无关,但常规出院回家比例较低。

研究设计与样本

  • 采用平衡评分匹配队列评估多发性硬化与手术结局的关联,匹配队列包含3530例患者。

主要发现

  • 多发性硬化队列较无多发性硬化队列更年轻(中位年龄63岁 vs 67岁),女性比例更高(56% vs 28%)。

临床怎么用

  • 外科医生可考虑与神经科专家团队协作,优化围术期管理以提高常规出院回家比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with multiple sclerosis (MS) have a higher incidence of heart failure and myocardial infarction. In patients with MS, autonomic dysregulation may cause detrimental hemodynamic instability perioperatively. However, data on outcomes of cardiac surgery in patients with MS are scarce. OBJECTIVES: To describe US nationwide morbidity and mortality in patients with MS undergoing cardiovascular surgery. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included records of patients who underwent coronary artery bypass grafting, valve, aortic, or combined cardiovascular surgery between 2016 and 2022 in the National Inpatient Sample database. The association between MS and surgical outcomes at admission was evaluated using a balancing-score matched cohort. Data were analyzed between November 1 and 26, 2025. EXPOSURE: Multiple sclerosis. MAIN OUTCOMES AND MEASURES: In-hospital mortality, complications, length of stay, costs, and discharge disposition. RESULTS: Records for 1 766 170 patients (3605 with MS and 1 762 565 without) were included. The MS cohort was younger (median [IQR] age, 63 [57-69] years vs 67 [58-70] years) and had a larger proportion of women (2025 [56%] vs 488 850 [28%]). Patients with MS, vs those without, exhibited higher frequencies of comorbidities, including chronic lung disease, depression, hypothyroidism, paralysis, psychosis, and valvular disease. In the matched cohorts of 3530 patients, mortality did not differ significantly between patients with MS and those without MS (70 [2.0%] vs 130 [3.7%]; P = .05). The prevalence of a composite complication end point was also comparable between groups (1770 [50%] vs 1810 [51%]; P = .67). This included similarities in prevalence of stroke, acute kidney failure, pulmonary embolism, deep vein thrombosis, gastrointestinal (GI) bleeding, non-GI bleeding, prolonged mechanical ventilation, tracheostomy, pneumonia, surgical site infection, sepsis, blood transfusion, pericardial effusion, fluid overload, and pacemaker requirement. However, discharge disposition differed significantly, with a lower prevalence of routine home discharges in the MS cohort (985 [28%] vs 1265 [36%]; P < .001). Median hospitalization cost ($41 285 [IQR, $31 508-$56 040] vs $40 328 [IQR, $30 604-$56 202]; P = .44) and median length of stay (8 [IQR, 6-12] days in both groups; P = .33) did not differ between cohorts. CONCLUSIONS AND RELEVANCE: This cross-sectional study suggests that MS is not associated with increased in-hospital mortality or complications in patients undergoing cardiovascular surgery, although the prevalence of routine home discharges was lower among patients with MS. Surgeons may consider a team approach with neurological experts to optimize perioperative care and increase routine home discharges.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Diz Ferre JL, Zhou G, Cabulong A, et al. Outcomes of Cardiovascular Surgery in Patients With Multiple Sclerosis. JAMA Surg. 2026. PMID: 42268624. doi:10.1001/jamasurg.2026.1951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。